Actively Recruiting
Real-World Study of PADN for the Treatment of PAH
Led by Pulnovo Medical (Wuxi) Co., Ltd. · Updated on 2025-06-26
200
Participants Needed
1
Research Sites
197 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Real-World Study of PADN for the Treatment of PAH
CONDITIONS
Official Title
Real-World Study of PADN for the Treatment of PAH
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with PAH and received PADN procedure since March 2024
- No contraindications to procedure
- Able to provide informed consent and authorize use of health/research data
- Compliant with treatment and follow-up requirements
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here